Molecular testing in Families with Familial Hypercholesterolemia in India

N. Setia, J.P.S. Sawhney, R. Saxena, R.D. Puri, A. Arora, I.C. Verma
2014 Indian Heart Journal  
Results: Successful reperfusion was achieved with tailored thrombolytic therapy in all patients. Only one patient had reinfarction on the 3 rd day, for which she received another half-dose Tenectaplase. She remained asymptomatic subsequently. 2 patients had IV site ecchymosis; no patient had major bleeding. All the patients had one month follow-up and were asymptomatic. Conclusion: Tailored thrombolytic therapy in very elderly patients, many of whom also have high bleeding risk factors, is
more » ... tive as well as safe. With the increasing lifespan, the number of very elderly patients with STEMI is going to increase in the future, posing a challenge of bleeding risk vs benefit with reperfusion strategies; tailored thrombolytic therapy would have greater relevance in the future and needs to be studied in larger number of patients.
doi:10.1016/j.ihj.2014.10.077 fatcat:hk4pkr44j5bxfidgstepyqxssy